Australia Questions Soliris Survival Benefit; Adds Listings From MSD, Novartis, Janssen To PBS
This article was originally published in PharmAsia News
Executive Summary
PERTH, Australia - Australia's Minister of Health Nicola Roxon requested advice from the Pharmaceutical Benefits Advisory Committee on the potential benefits of adding Alexion's Soliris (eculizumab) to the government's Life Saving Drugs Program (LSDP)